CRISPR-Cas9 technology: A new direction for personalized medicine in respiratory disease?
Respirology (Carlton, Vic.), 24(7): 614-615 PMID 31033105 DOI 10.1111/resp.13570
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.